Innovative OTC Stock Performance

IMTH -  USA Stock  

USD 0.50  0.00  0.00%

Innovative Medtech holds a performance score of 6 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 2.2094, which attests to a somewhat significant risk relative to the market. Let's try to break down what Innovative's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Innovative Medtech will likely underperform. Although it is essential to pay attention to Innovative Medtech current price history, it is also good to be reasonable about what you can do with equity current price movements. Our philosophy towards determining future potential of any stock is to look not only at its past charts but also at the business as a whole, including all available fundamental and technical indicators. To evaluate if Innovative Medtech expected return of 4.03 will be sustainable into the future, we have found twenty-one different technical indicators, which can help you to check if the expected returns are sustainable. Use Innovative Medtech coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to analyze future returns on Innovative Medtech.

Innovative O TC Stock Performance 

 
Refresh
 Innovative Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medtech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Innovative Medtech reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Innovative Price Channel

Fifty Two Week Low0.2501
Fifty Two Week High37.0000

Innovative Medtech Relative Risk vs. Return Landscape

If you would invest  150.00  in Innovative Medtech on July 19, 2021 and sell it today you would lose (100.00)  from holding Innovative Medtech or give up 66.67% of portfolio value over 90 days. Innovative Medtech is currently generating 4.0279% in daily expected returns and assumes 46.2401% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Innovative, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Innovative Medtech is expected to generate 62.9 times more return on investment than the market. However, the company is 62.9 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The DOW is currently generating roughly 0.08 per unit of risk.

Innovative Medtech Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovative Medtech's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Innovative Medtech, and traders can use it to determine the average amount a Innovative Medtech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0871

Best
Portfolio
Best
Equity
IMTH
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 46.24
  actual daily
 
 96 %
of total potential
 
9696
Expected Return
 4.03
  actual daily
 
 76 %
of total potential
 
7676
Risk-Adjusted Return
 0.09
  actual daily
 
 6 %
of total potential
 
66
Based on monthly moving average Innovative Medtech is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innovative Medtech by adding it to a well-diversified portfolio.

About Innovative Medtech Performance

To evaluate Innovative Medtech OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Innovative Medtech generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Innovative OTC Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Innovative Medtech stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Innovative's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Innovative MedTech Inc. provides natural and organic food products. It offers bars and pizza products. The company was formerly known as Fresh Harvest Products, Inc. and changed its name to Innovative MedTech Inc. in March 2021. Innovative MedTech Inc. is headquartered in New York, New York.

Things to note about Innovative Medtech

Checking the ongoing alerts about Innovative Medtech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Innovative Medtech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Innovative Medtech Alerts

Equity Alerts and Improvement Suggestions

Innovative Medtech is way too risky over 90 days horizon
Innovative Medtech has some characteristics of a very speculative penny stock
Innovative Medtech appears to be risky and price may revert if volatility continues
Innovative Medtech has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (365.34 K).
Innovative Medtech currently holds about 608 in cash with (4.39 K) of positive cash flow from operations.
Latest headline from www.nasdaq.com: This Unstoppable Cancer-Treatment Companys Stock Is on Sale Now - Nasdaq
Please see Risk vs Return Analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.